Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
afatinib
1200.32
NCT00949650
Carcinoma, Non-Small-Cell Lung; Adenocarcinoma
Phase 3
 
November 2014

Powered by ideaPoint, Inc.